According to Latest Study, the global market for Neuroscience Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Neuroscience Antibody market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Neuroscience Antibody market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals and Diagnostics Centers grew percent to account for percent of the total market sales, and Academic and Research Institutes grew percent.
Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies.
This report studies and analyses global Neuroscience Antibody status and future trends, helps the client to determine the Neuroscience Antibody market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Neuroscience Antibody, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Neuroscience Antibody market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Neuroscience Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Neuroscience Antibody sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Neuroscience Antibody key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Neuroscience Antibody key producing regions, capacity, production, and year over year growth
(6) Neuroscience Antibody industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc
Santa Cruz Biotechnology Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience
Market segment by Type, covers
Antibodies
Research Reagents
Market segment by Application, can be divided into
Hospitals and Diagnostics Centers
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Neuroscience Antibody product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Neuroscience Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Neuroscience Antibody market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Neuroscience Antibody, percent & CAGR, 2018-2029
Chapter 5: Neuroscience Antibody industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Neuroscience Antibody Definition
1.2 Global Neuroscience Antibody Market Size and Forecast
1.2.1 By Consumption Value, Global Neuroscience Antibody Market Size,2018-2029
1.2.2 By Sales Quantity, Global Neuroscience Antibody Market Size,2018-2029
1.2.3 Global Neuroscience Antibody Average Selling Price (ASP),2018-2029
1.3 China Neuroscience Antibody Market Size and Forecast
1.3.1 By Consumption Value, China Neuroscience Antibody Market Size,2018-2029
1.3.2 By Sales Quantity, China Neuroscience Antibody Market Size,2018-2029
1.3.3 China Neuroscience Antibody Average Selling Price (ASP), 2018-2029
1.4 Share of China Neuroscience Antibody Market with Respect to the Global Market
1.4.1 By Consumption Value, China Neuroscience Antibody Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Neuroscience Antibody Market Share in Global, 2018-2029
1.4.3 Neuroscience Antibody Market Size: China VS Global, 2018-2029
1.5 Neuroscience Antibody Market Dynamics
1.5.1 Neuroscience Antibody Market Drivers
1.5.2 Neuroscience Antibody Market Restraints
1.5.3 Neuroscience Antibody Industry Trends
1.5.4 Neuroscience Antibody Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Neuroscience Antibody, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Neuroscience Antibody, Global Market Share by Company, 2018-2023
2.3 Neuroscience Antibody Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Neuroscience Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Neuroscience Antibody Concentration Ratio
2.6 Global Neuroscience Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global Neuroscience Antibody Manufacturers Product Type
2.8 Head Office and Neuroscience Antibody Production Site of Key Manufacturer
2.9 Neuroscience Antibody Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Neuroscience Antibody, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Neuroscience Antibody, China Market Share by Company, 2018-2023
3.3 China Neuroscience Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Neuroscience Antibody Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Neuroscience Antibody Capacity by Region
4.3 Global Neuroscience Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Neuroscience Antibody Production by Region, 2018-2029
4.5 Global Neuroscience Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Neuroscience Antibody Industry Chain
5.2 Neuroscience Antibody Upstream Analysis
5.2.1 Neuroscience Antibody Core Raw Materials
5.2.2 Main Manufacturers of Neuroscience Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Neuroscience Antibody Production Mode
5.6 Neuroscience Antibody Procurement Model
5.7 Neuroscience Antibody Industry Sales Model and Sales Channels
5.7.1 Neuroscience Antibody Sales Model
5.7.2 Neuroscience Antibody Typical Distributors
6 Sights by Type
6.1 Neuroscience Antibody Classification
6.1.1 Antibodies
6.1.2 Research Reagents
6.2 By Type, Global Neuroscience Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Neuroscience Antibody Consumption Value, 2018-2029
6.4 By Type, Global Neuroscience Antibody Sales Quantity, 2018-2029
6.5 By Type, Global Neuroscience Antibody Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Neuroscience Antibody Segment by Application
7.1.1 Hospitals and Diagnostics Centers
7.1.2 Academic and Research Institutes
7.1.3 Pharmaceutical and Biotechnology Companies
7.2 By Application, Global Neuroscience Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Neuroscience Antibody Consumption Value, 2018-2029
7.4 By Application, Global Neuroscience Antibody Sales Quantity, 2018-2029
7.5 By Application, Global Neuroscience Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Neuroscience Antibody Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Neuroscience Antibody Consumption Value, 2018-2029
8.3 By Region, Global Neuroscience Antibody Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Neuroscience Antibody & Forecasts, 2018-2029
8.4.2 By Country, North America Neuroscience Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe Neuroscience Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Neuroscience Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Neuroscience Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Neuroscience Antibody Market Size Market Share
8.7 South America
8.7.1 South America Neuroscience Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Neuroscience Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Neuroscience Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Neuroscience Antibody Consumption Value, 2018-2029
9.3 By Country, Global Neuroscience Antibody Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Neuroscience Antibody Market Size, 2018-2029
9.4.2 By Type, U.S. Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Neuroscience Antibody Market Size, 2018-2029
9.5.2 By Type, Europe Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Neuroscience Antibody Market Size, 2018-2029
9.6.2 By Type, China Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Neuroscience Antibody Market Size, 2018-2029
9.7.2 By Type, Japan Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Neuroscience Antibody Market Size, 2018-2029
9.8.2 By Type, South Korea Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Neuroscience Antibody Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Neuroscience Antibody Market Size, 2018-2029
9.10.2 By Type, India Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Neuroscience Antibody Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abcam
10.1.1 Abcam Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abcam Neuroscience Antibody Models, Specifications, and Application
10.1.3 Abcam Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abcam Company Profile and Main Business
10.1.5 Abcam Recent Developments
10.2 BioLegend
10.2.1 BioLegend Company Information, Head Office, Market Area, and Industry Position
10.2.2 BioLegend Neuroscience Antibody Models, Specifications, and Application
10.2.3 BioLegend Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 BioLegend Company Profile and Main Business
10.2.5 BioLegend Recent Developments
10.3 Bio-Rad Laboratories Inc
10.3.1 Bio-Rad Laboratories Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 Bio-Rad Laboratories Inc Neuroscience Antibody Models, Specifications, and Application
10.3.3 Bio-Rad Laboratories Inc Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Bio-Rad Laboratories Inc Company Profile and Main Business
10.3.5 Bio-Rad Laboratories Inc Recent Developments
10.4 Cell Signaling Technology
10.4.1 Cell Signaling Technology Company Information, Head Office, Market Area, and Industry Position
10.4.2 Cell Signaling Technology Neuroscience Antibody Models, Specifications, and Application
10.4.3 Cell Signaling Technology Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Cell Signaling Technology Company Profile and Main Business
10.4.5 Cell Signaling Technology Recent Developments
10.5 Roche
10.5.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.5.2 Roche Neuroscience Antibody Models, Specifications, and Application
10.5.3 Roche Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Roche Company Profile and Main Business
10.5.5 Roche Recent Developments
10.6 Genscript Biotech Corp
10.6.1 Genscript Biotech Corp Company Information, Head Office, Market Area, and Industry Position
10.6.2 Genscript Biotech Corp Neuroscience Antibody Models, Specifications, and Application
10.6.3 Genscript Biotech Corp Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Genscript Biotech Corp Company Profile and Main Business
10.6.5 Genscript Biotech Corp Recent Developments
10.7 Merck KGaA
10.7.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
10.7.2 Merck KGaA Neuroscience Antibody Models, Specifications, and Application
10.7.3 Merck KGaA Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Merck KGaA Company Profile and Main Business
10.7.5 Merck KGaA Recent Developments
10.8 Rockland Immunochemicals Inc
10.8.1 Rockland Immunochemicals Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 Rockland Immunochemicals Inc Neuroscience Antibody Models, Specifications, and Application
10.8.3 Rockland Immunochemicals Inc Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Rockland Immunochemicals Inc Company Profile and Main Business
10.8.5 Rockland Immunochemicals Inc Recent Developments
10.9 Santa Cruz Biotechnology Inc
10.9.1 Santa Cruz Biotechnology Inc Company Information, Head Office, Market Area, and Industry Position
10.9.2 Santa Cruz Biotechnology Inc Neuroscience Antibody Models, Specifications, and Application
10.9.3 Santa Cruz Biotechnology Inc Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Santa Cruz Biotechnology Inc Company Profile and Main Business
10.9.5 Santa Cruz Biotechnology Inc Recent Developments
10.10 Siemens Healthineers
10.10.1 Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position
10.10.2 Siemens Healthineers Neuroscience Antibody Models, Specifications, and Application
10.10.3 Siemens Healthineers Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Siemens Healthineers Company Profile and Main Business
10.10.5 Siemens Healthineers Recent Developments
10.11 Tecan Group Ltd
10.11.1 Tecan Group Ltd Company Information, Head Office, Market Area, and Industry Position
10.11.2 Tecan Group Ltd Neuroscience Antibody Models, Specifications, and Application
10.11.3 Tecan Group Ltd Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Tecan Group Ltd Company Profile and Main Business
10.11.5 Tecan Group Ltd Recent Developments
10.12 Thermo Fisher Scientific Inc
10.12.1 Thermo Fisher Scientific Inc Company Information, Head Office, Market Area, and Industry Position
10.12.2 Thermo Fisher Scientific Inc Neuroscience Antibody Models, Specifications, and Application
10.12.3 Thermo Fisher Scientific Inc Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Thermo Fisher Scientific Inc Company Profile and Main Business
10.12.5 Thermo Fisher Scientific Inc Recent Developments
10.13 Enzo Life Sciences AG
10.13.1 Enzo Life Sciences AG Company Information, Head Office, Market Area, and Industry Position
10.13.2 Enzo Life Sciences AG Neuroscience Antibody Models, Specifications, and Application
10.13.3 Enzo Life Sciences AG Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Enzo Life Sciences AG Company Profile and Main Business
10.13.5 Enzo Life Sciences AG Recent Developments
10.14 Neobioscience
10.14.1 Neobioscience Company Information, Head Office, Market Area, and Industry Position
10.14.2 Neobioscience Neuroscience Antibody Models, Specifications, and Application
10.14.3 Neobioscience Neuroscience Antibody Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Neobioscience Company Profile and Main Business
10.14.5 Neobioscience Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Neuroscience Antibody Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Neuroscience Antibody Market Restraints
Table 3. Neuroscience Antibody Market Trends
Table 4. Neuroscience Antibody Industry Policy
Table 5. Global Neuroscience Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Neuroscience Antibody Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Neuroscience Antibody Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Neuroscience Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Neuroscience Antibody Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Neuroscience Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Neuroscience Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global Neuroscience Antibody Manufacturers Product Type
Table 13. Head Office and Neuroscience Antibody Production Site of Key Manufacturer
Table 14. Neuroscience Antibody Capacity of Major Manufacturers and Future Plan
Table 15. China Neuroscience Antibody Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Neuroscience Antibody Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Neuroscience Antibody Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Neuroscience Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Neuroscience Antibody Production by Region, 2018-2023, (K Units)
Table 20. Global Neuroscience Antibody Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Neuroscience Antibody Upstream (Raw Materials)
Table 22. Global Neuroscience Antibody Typical Customers
Table 23. Neuroscience Antibody Typical Distributors
Table 24. By Type, Global Neuroscience Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Neuroscience Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Neuroscience Antibody Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Neuroscience Antibody Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Neuroscience Antibody Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Neuroscience Antibody Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Neuroscience Antibody Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Neuroscience Antibody Sales Quantity Market Share, 2018-2029
Table 34. Abcam Company Information, Head Office, Market Area, and Industry Position
Table 35. Abcam Neuroscience Antibody Models, Specifications, and Application
Table 36. Abcam Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Abcam Company Profile and Main Business
Table 38. Abcam Recent Developments
Table 39. BioLegend Company Information, Head Office, Market Area, and Industry Position
Table 40. BioLegend Neuroscience Antibody Models, Specifications, and Application
Table 41. BioLegend Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. BioLegend Company Profile and Main Business
Table 43. BioLegend Recent Developments
Table 44. Bio-Rad Laboratories Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Bio-Rad Laboratories Inc Neuroscience Antibody Models, Specifications, and Application
Table 46. Bio-Rad Laboratories Inc Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Bio-Rad Laboratories Inc Company Profile and Main Business
Table 48. Bio-Rad Laboratories Inc Recent Developments
Table 49. Cell Signaling Technology Company Information, Head Office, Market Area, and Industry Position
Table 50. Cell Signaling Technology Neuroscience Antibody Models, Specifications, and Application
Table 51. Cell Signaling Technology Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Cell Signaling Technology Company Profile and Main Business
Table 53. Cell Signaling Technology Recent Developments
Table 54. Roche Company Information, Head Office, Market Area, and Industry Position
Table 55. Roche Neuroscience Antibody Models, Specifications, and Application
Table 56. Roche Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Roche Company Profile and Main Business
Table 58. Roche Recent Developments
Table 59. Genscript Biotech Corp Company Information, Head Office, Market Area, and Industry Position
Table 60. Genscript Biotech Corp Neuroscience Antibody Models, Specifications, and Application
Table 61. Genscript Biotech Corp Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Genscript Biotech Corp Company Profile and Main Business
Table 63. Genscript Biotech Corp Recent Developments
Table 64. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 65. Merck KGaA Neuroscience Antibody Models, Specifications, and Application
Table 66. Merck KGaA Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Merck KGaA Company Profile and Main Business
Table 68. Merck KGaA Recent Developments
Table 69. Rockland Immunochemicals Inc Company Information, Head Office, Market Area, and Industry Position
Table 70. Rockland Immunochemicals Inc Neuroscience Antibody Models, Specifications, and Application
Table 71. Rockland Immunochemicals Inc Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Rockland Immunochemicals Inc Company Profile and Main Business
Table 73. Rockland Immunochemicals Inc Recent Developments
Table 74. Santa Cruz Biotechnology Inc Company Information, Head Office, Market Area, and Industry Position
Table 75. Santa Cruz Biotechnology Inc Neuroscience Antibody Models, Specifications, and Application
Table 76. Santa Cruz Biotechnology Inc Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Santa Cruz Biotechnology Inc Company Profile and Main Business
Table 78. Santa Cruz Biotechnology Inc Recent Developments
Table 79. Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position
Table 80. Siemens Healthineers Neuroscience Antibody Models, Specifications, and Application
Table 81. Siemens Healthineers Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Siemens Healthineers Company Profile and Main Business
Table 83. Siemens Healthineers Recent Developments
Table 84. Tecan Group Ltd Company Information, Head Office, Market Area, and Industry Position
Table 85. Tecan Group Ltd Neuroscience Antibody Models, Specifications, and Application
Table 86. Tecan Group Ltd Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Tecan Group Ltd Company Profile and Main Business
Table 88. Tecan Group Ltd Recent Developments
Table 89. Thermo Fisher Scientific Inc Company Information, Head Office, Market Area, and Industry Position
Table 90. Thermo Fisher Scientific Inc Neuroscience Antibody Models, Specifications, and Application
Table 91. Thermo Fisher Scientific Inc Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Thermo Fisher Scientific Inc Company Profile and Main Business
Table 93. Thermo Fisher Scientific Inc Recent Developments
Table 94. Enzo Life Sciences AG Company Information, Head Office, Market Area, and Industry Position
Table 95. Enzo Life Sciences AG Neuroscience Antibody Models, Specifications, and Application
Table 96. Enzo Life Sciences AG Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Enzo Life Sciences AG Company Profile and Main Business
Table 98. Enzo Life Sciences AG Recent Developments
Table 99. Neobioscience Company Information, Head Office, Market Area, and Industry Position
Table 100. Neobioscience Neuroscience Antibody Models, Specifications, and Application
Table 101. Neobioscience Neuroscience Antibody Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Neobioscience Company Profile and Main Business
Table 103. Neobioscience Recent Developments
List of Figures
Figure 1. Neuroscience Antibody Picture
Figure 2. Global Neuroscience Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Neuroscience Antibody Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Neuroscience Antibody Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Neuroscience Antibody Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Neuroscience Antibody Sales Quantity (K Units) & (2018-2029)
Figure 7. China Neuroscience Antibody Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Neuroscience Antibody Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Neuroscience Antibody Market Share of Global, 2018-2029
Figure 10. Global Neuroscience Antibody Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Neuroscience Antibody Key Participants, Market Share, 2022
Figure 12. Global Neuroscience Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Neuroscience Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Neuroscience Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 15. Neuroscience Antibody Industry Chain
Figure 16. Neuroscience Antibody Procurement Model
Figure 17. Neuroscience Antibody Sales Model
Figure 18. Neuroscience Antibody Sales Channels, Direct Sales, and Distribution
Figure 19. Antibodies
Figure 20. Research Reagents
Figure 21. By Type, Global Neuroscience Antibody Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Neuroscience Antibody Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Neuroscience Antibody Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Neuroscience Antibody Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospitals and Diagnostics Centers
Figure 27. Academic and Research Institutes
Figure 28. Pharmaceutical and Biotechnology Companies
Figure 29. By Application, Global Neuroscience Antibody Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Neuroscience Antibody Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Neuroscience Antibody Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Neuroscience Antibody Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Neuroscience Antibody Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Neuroscience Antibody Sales Quantity Market Share, 2018-2029
Figure 36. North America Neuroscience Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Neuroscience Antibody Consumption Value Market Share, 2022
Figure 38. Europe Neuroscience Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Neuroscience Antibody Consumption Value Market Share, 2022
Figure 40. Asia Pacific Neuroscience Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Neuroscience Antibody Consumption Value Market Share, 2022
Figure 42. South America Neuroscience Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Neuroscience Antibody Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Neuroscience Antibody Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Neuroscience Antibody Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Neuroscience Antibody Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|